搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
17 小时
WAVE Life Sciences股票目标价上调,维持买入评级,因研究数据积极
H.C. Wainwright周二调整了对WAVE Life Sciences (NASDAQ:WVE)股票的展望,将目标价从之前的$15上调至$22,同时维持对该股的买入评级。该公司的决定是在WVE-N531研究的中期数据发布之后做出的,该研究正在评估其治疗杜氏肌营养不良症(DMD)的潜力。 中期数据显示了显著的肌肉营养蛋白表达水平、安全性和剂量,平均绝对肌肉含量调整后的肌肉营养蛋白表达为9%( ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Would-be assassin charged
Penn suspends law professor
Campaign office damaged
Gets 2-yrs for role in fraud
Woman dies in 'suicide pod’
Calls strike against 'LoL’
US to waive visas for Qatar
Texas AG appeal denied
Rioter mistakenly released
NYC schools boss retiring
‘Trump Train’ jury verdict
Food packaging cancer risk
InfoWars to be auctioned off
X account hacked
Executed by lethal injection
Johnny Cash statue unveiled
ISR: Hezbollah leader killed
NC sending absentee ballots
PA county ballot ruling
Dali owner, operator sued
EEOC blocked on rules
Partners with Google
Recalls 41K+ motorcycles
Phoenix breaks heat record
Pac-12 sues Mountain West
Retiring after 14 seasons
Pres candidates' security bill
Severe obesity on the rise
Union gets more voting time
$375M military aid to UKR
反馈